Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: A double-blind, randomized, placebo-controlled trial

Bipolar Disorders

Volumn 14, Issue 1, 2012, Pages 64-70

  Anand, Amit ^a   Gunn, Abigail D ^a   Barkay, Gavriel ^b   Karne, Harish S ^a   Nurnberger, John I ^a   Mathew, Sanjay J ^c   Ghosh, Samiran ^d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Antidepressants; Bipolar depression; Clinical trial; Glutamate; Lamotrigine; Memantine; N methyl D aspartate (NMDA) receptor

Indexed keywords

LAMOTRIGINE; MEMANTINE; PLACEBO;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; ALZHEIMER DISEASE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BEHAVIOR; BIPOLAR DEPRESSION; BLURRED VISION; BREAST DISCHARGE; CHEST TIGHTNESS; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONCENTRATION LOSS; CONSTIPATION; CONTROLLED STUDY; COUGHING; DECREASED APPETITE; DEHYDRATION; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; EXPLORATORY RESEARCH; FATIGUE; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; HYPERTENSION; HYPOMANIA; INDIGESTION; INSOMNIA; LIBIDO; LYMPHADENOPATHY; MALE; MICTURITION DISORDER; MUSCLE SPASM; MUSCLE WEAKNESS; NAUSEA; NIGHT SWEAT; NIGHTMARE; OUTPATIENT; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SIDE EFFECT; SOMNOLENCE; THORAX PAIN; TREATMENT DURATION; TREATMENT RESPONSE; TWITCHING MOTILITY; VOMITING; XEROSTOMIA; YOUNG MANIA RATING SCALE;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; DEPRESSION; DOPAMINE AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GLUTAMIC ACID; HUMANS; MALE; MEMANTINE; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME; TRIAZINES;

EID: 84856875518     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2011.00971.x     Document Type: Article

References (26)

1. Niswender CM, Conn PJ. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Ann Rev Pharmacol Toxicol 2010; 50: 295-322.
2. Sanacora G, Zarate CA Jr, Krystal JH, Manji HK. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov 2008; 7: 426-437.
3. Murrough JW, Charney DS. Cracking the moody brain: lifting the mood with ketamine. Nat Med 2010; 16: 1384-1385.
4. Krystal JH. N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants. Arch Gen Psychiatry 2010; 67: 1110-1111.
5. Trullas R, Skolnick P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 1990; 185: 1-10.
6. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999; 60: 79-88.
7. Anand A, Charney DS, Oren DA et al. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry 2000; 57: 270-276.
8. Krystal JH, Karper LP, Seibyl JP et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994; 51: 199-214.
9. Berman RM, Cappiello A, Anand A et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000; 47: 351-354.
10. Diazgranados N, Ibrahim L, Brutsche NE et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 2010; 67: 793-802.
11. Price RB, Nock MK, Charney DS, Mathew SJ. Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry 2009; 66: 522-526.
12. Zarate CA Jr, Singh JB, Carlson PJ et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63: 856-864.
13. Pittenger C, Coric V, Banasr M, Bloch M, Krystal JH, Sanacora G. Riluzole in the treatment of mood and anxiety disorders. CNS Drugs 2008; 22: 761-786.
14. Zarate CA Jr, Payne JL, Quiroz J et al. An open-label trial of riluzole in patients with treatment-resistant major depression. Am J Psychiatry 2004; 161: 171-174.
15. Sanacora G, Kendell SF, Fenton L, Coric V, Krystal JH. Riluzole augmentation for treatment-resistant depression. Am J Psychiatry 2004; 161: 2132.
16. Zarate CA Jr, Quiroz JA, Singh JB et al. An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry 2005; 57: 430-432.
17. Mathew SJ, Murrough JW, aan het Rot M, Collins KA, Reich DL, Charney DS. Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial. The Inter J Neuropsychopharmacol 2009; 13: 71-82.
18. Johnson JW, Kotermanski SE. Mechanism of action of memantine. Curr Opin Pharmacol 2006; 6: 61-67.
19. Zarate CA Jr, Singh JB, Quiroz JA et al. A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am J Psychiatry 2006; 163: 153-155.
20. Moghaddam B, Adams B, Verma A, Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 1997; 17: 2921-2927.
21. Naskar R, Vorwerk CK, Dreyer EB. Concurrent downregulation of a glutamate transporter and receptor in glaucoma. Invest Ophthalmol Vis Sci 2000; 41: 1940-1944.
22. Consoni FT, Vital MABF, Andreatini R. Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test. Eur Neuropsychopharmacol 2006; 16: 451-458.
23. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
24. Young RC, Schreiber MT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
25. Fournier JC, DeRubeis RJ, Hollon SD et al. Antidepressant drug effects and depression severity. JAMA 2010; 303: 47-53.
26. Chengappa KNR, Levine J, Gershon S et al. Inositol as an add-on treatment for bipolar depression. Bipolar Disord 2000; 2: 47-55.